Clinical trials reveal 539% hair regrowth from new drug
These findings will facilitate potential Food and Drug Administration authorization in 2026, potentially establishing clascoterone as the first genuinely innovative ...
These findings will facilitate potential Food and Drug Administration authorization in 2026, potentially establishing clascoterone as the first genuinely innovative ...
The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.
All rights reserved to Israel Hayom
Hosted by sPD.co.il
[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]